New combo treatment for melasma shows promise in early trial
NCT ID NCT07448415
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking tranexamic acid pills along with a microneedling procedure that delivers glutathione into the skin works better for melasma than either treatment alone. Forty-two women with facial melasma will be split into groups to compare the approaches. The main goal is to see how much the dark patches improve over three months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tranexamic acid (oral) and glutathione (topical)
- What this could lead to
- If it works, this could offer a more effective combination treatment for melasma, a common skin condition causing dark patches.
- What could go wrong
- This is a small, early-phase trial with only 42 participants. Results may not apply to everyone, and side effects like bleeding or skin irritation are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Can sunscreen do more than protect? study tests if it fades dark spots
- New cream trio aims to outshine standard melasma treatment
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
- New serums take on hydroquinone in skin brightening showdown